Move to topTop
November 10, 2020

AFRICA - November 10, 2020 - Today, a collaboration of stakeholders in the public and private sectors across sub-Saharan Africa (SSA) launched the Coalition of Blood for Africa (CoBA) on a virtual platform. This reflects a growing consensus that progress toward adequate, safe and sustainable blood in Africa requires multi-stakeholder, multi-pronged and innovative approaches to impact lives across the continent.

Blood is a vital healthcare resource. It is most often used in Africa to treat pregnancy-related complications and severe childhood anemia that is caused by a variety of contributors including malaria and sickle cell disease. Blood is increasingly important for patients with kidney failure who are on dialysis and to help cancer patients.

The World Health Organization (WHO) states that the number of units of blood needed to sustain an adequate level of health equals 1% of a nation's population - 10 units per 1000 people. Yet many African countries fall well short of the minimum goal. The lack of infrastructure and equipment for collection and processing of blood components is a key impediment to providing a sustainable blood supply. Though blood and safe transfusion services are essential parts of any strong health system, the safety, sustainability and adequacy of blood remains a major health challenge in many African countries.

"Today is about mobilizing action, as we convene the first ever Coalition of Blood in Africa," said Antoinette Gawin, President and Chief Executive Officer, Terumo Blood and Cell Technologies. "The coalition's goal is to support the World Health Organization's commitments [WHA63.12] and aligns with our global mission to serve more patients. Providing safe access to blood in Africa is one way to achieve this."

The coalition is anchored on three pillars:

  • ・Reflection - Supporting informed-decision making with research, policy analysis and data collection
  • ・Dialogue - Creating awareness about the need for blood and blood safety
  • ・Action - Providing technical assistance to support initiatives, capacity-building programs and activities like blood collection drives; helping with technical inputs to strengthen blood-related legislation ad policies, such as guidelines for the management of sickle cell disease

The coalition brings together an unprecedented array of health experts, including public-sector research institutes, ministries of health, academia, not-for-profit research and development organizations, NGOs, international organizations and funders all committed to finding solutions to address the challenges facing access to safe, sustainable blood in Africa.

"The scale of the challenge is clearly beyond the scope of a single organization and I am confident that the Coalition will facilitate a coordinated approach to address the challenges facing blood in Africa and find sustainable solutions," says Gavin Evans, Executive Director, Global Blood Fund.

The launch of CoBA was convened by Terumo Blood and Cell Technologies, a global leader in blood component, therapeutic apheresis and cell technology, in collaboration with Global Blood Fund, Africa Practice and Africa Health Business.

  • 20201110.png

About Terumo Blood and Cell Technologies

Terumo Blood and Cell Technologies is a medical device company. Our products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions. Our employees around the world believe in the potential of blood and cells to do even more for patients than they do today. TERUMOBCT.COM

About Africa Practice

Africa Practice is an Africa-focused strategic advisory firm operating at the intersect of industry and government. We combine insights and advocacy, enabling our clients to navigate complex stakeholder ecosystems and lead with confidence. We believe sustainable performance depends on managing political and policy risk, doing no harm, building trust and delivering meaningful social and economic impact.
Over the past 16 years we have advised some of the largest institutions and investors in Africa and delivered assignments in over 45 countries, building deep sector knowledge in the process.

About Africa Health Business

Africa Health Business (AHB) is a pan-African consultancy, advisory and investment firm with a combined experience of 35+ years in the African (private) healthcare space. AHB is committed to strengthening healthcare systems in Africa and ensuring equitable access to healthcare for all through innovative partnerships.

About Global Blood Fund

Global Blood Fund (GBF) is a US and UK registered charity. Since 2008, GBF has been working to address the inequalities in blood safety and sufficiency that exist between wealthier nations and low- and middle-income countries. It does this by providing funding, training, equipment and other forms of support, often bringing together stakeholders within the blood banking community to effect change.

About Terumo

Terumo (TSE: 4543) is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for 100 years. Based in Tokyo and operating globally, Terumo employs more than 28,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.

Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts or projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.


Information about products (including products currently in development) included in this material is not intended to constitute an advertisement or medical advice.